Designing and implementing the IDEAL Study: A randomized clinical trial of <i>APOE</i> genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population

The <i>Información de la Enfermedad de Alzheimer para Latinos</i> (IDEAL) Study investigates apolipoprotein E (<i>APOE</i>) genotype disclosure among Latinos using mixed methods.We recruited adults 40-64 years of age without Alzheimer's disease (AD) for a community-based survey and randomized trial.Trial participants receives AD risk estimates with or without <i>APOE</i> genotypes.Psychosocial, behavioral, and cognitive impacts are assessed over 15 months.Findings may inform AD educational materials and genetic counseling protocols.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia Translational Research & Clinical Interventions
Published
2024-10-01
DOI
https://doi.org/10.1002/trc2.70016
Citations
3
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
1.16

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population

Sophia Rodriguez, J. Scott Roberts, Ruth Ottman, Jonathan D Godinez et al.
3 citations
Alzheimer s & Dementia Translational Research & Clinical Interventions
Dementia and Cognitive Impairment Research
1.16
article

Designing and implementing the IDEAL Study: A randomized clinical trial of APOE genotype disclosure for late‐onset Alzheimer's disease in an urban Latino population

Sophia Rodriguez, J. Scott Roberts, Ruth Ottman, Jonathan D Godinez, María Cabán, Daniela Diaz, Rebecca Ferber, Cheng‐Shiun Leu, Wendy R. Uhlmann, Itzel A. Camarillo, Jill Goldman, Drew Blasco, Karolynn Siegel, Ana F Abraido‐Lanza, John B. Wetmore, Rafael Lantigua, Wendy K. Chung
article en
3 citations

Abstract

The <i>Información de la Enfermedad de Alzheimer para Latinos</i> (IDEAL) Study investigates apolipoprotein E (<i>APOE</i>) genotype disclosure among Latinos using mixed methods.We recruited adults 40-64 years of age without Alzheimer's disease (AD) for a community-based survey and randomized trial.Trial participants receives AD risk estimates with or without <i>APOE</i> genotypes.Psychosocial, behavioral, and cognitive impacts are assessed over 15 months.Findings may inform AD educational materials and genetic counseling protocols.

Alzheimer s & Dementia Translational Research & Clinical InterventionsVol. 10(4)
Boston Children's Hospital (US), Michigan Department of Health and Human Services (US), University of Nevada, Las Vegas (US), Harvard University (US), University of Michigan (US), Columbia University Irving Medical Center (US), New York State Office of Mental Health (US), New York State Psychiatric Institute, Columbia University (US)
National Institutes of Health, National Institute on Aging, National Human Genome Research Institute, National Center for Advancing Translational Sciences
Quality Education
Openalex Percentile: Top 19%
Dementia and Cognitive Impairment Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.